CDC Issues New Guidance Recommending Monkeypox Antiviral Tecovirimat Be Limited To People At High Risk For Severe Disease

The Washington Post (9/15, Sun, Diamond) reports the CDC “issued new guidance Thursday recommending that TPoxx [tecovirimat], the only drug available to treat monkeypox, be limited to people at high risk for severe disease even as the outbreak that has in...